Previous studies have suggested that NF-κB nuclear localization sequence (NLS) peptide can targeting NF-κB nuclear translocation hampers inflammation and atherosclerosis development (Mallavia et al., 2013). The gene discussed is NFKB1; the disease is atherosclerosis.